Rethinking Access to Disability Benefits Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments. by Jen Tota McGivney Expanding Immunotherapy At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people. by Kevin McLaughlin Should All Kids With Cancer Get Genetic Testing? Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members. by Marcus A. Banks Understanding How Radiation Causes Cancer Researchers are investigating who is at greatest risk for radiation-induced cancers. by Kate Yandell How Long Do Immunotherapy Side Effects Last? For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild. by Anna Goshua Making Connections at the AACR Annual Meeting 2021 Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience. by Bradley Jones Building COVID-19 Vaccine Confidence Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population. by Kevin McLaughlin Chemobrain: It’s Not Your Imagination Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021. by Marci A. Landsmann Coverage of the AACR Annual Meeting 2021 This year’s AACR Annual Meeting features the latest advances in basic, translational and clinical cancer research. The more than 13,000 attendees at the virtual event represent more than 70 countries. by Kevin McLaughlin Searching the Blood for Signs of Altered Immunity The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors. by Kate Yandell next